Geno
|
Mag
|
Summary
|
(T;T)
|
0
|
common in clinvar
|
aka c.2573T>A, p.Leu858Gln or L858Q, and also c.2573T>G, p.Leu858Arg or L858R
The L858Q variant (in the EGFR gene) is reported in ClinVar as a germline variant considered likely pathogenic in association with non-small cell lung cancer.
The L858R variant is reported in ClinVar primarily as a somatic (not germline) variant, observed in tumors and reported to be predictive of response to various chemotherapeutics used to treat non-small cell lung cancer.
ClinVar
|
Risk
|
rs121434568(A;A) rs121434568(G;G) |
Alt
|
rs121434568(A;A) rs121434568(G;G) |
Reference
|
Rs121434568(T;T) |
Significance |
Drug-response |
Disease |
Non-small cell lung cancer Nonsmall cell lung cancer Adenocarcinoma of lung Tyrosine kinase inhibitor response carboplatin gefitinib response - Efficacy erlotinib response - Efficacy Adenocarcinoma of lung |
Variation | info |
---|
Gene |
EGFR |
CLNDBN |
Non-small cell lung cancer Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in, somatic Adenocarcinoma of lung, response to tyrosine kinase inhibitor in, somatic Tyrosine kinase inhibitor response carboplatin, docetaxel, erlotinib, gemcitabine, and paclitaxel response - Efficacy gefitinib response - Efficacy erlotinib response - Efficacy Adenocarcinoma of lung |
Reversed |
0 |
HGVS |
NC_000007.13:g.55259515T>A; NC_000007.13:g.55259515T>G |
CLNSRC |
OMIM Allelic Variant PharmGKB Clinical Annotation UniProtKB (protein) |
CLNACC |
RCV000419082.1, RCV000018083.87, RCV000018084.61, RCV000150629.1, RCV000211235.1, RCV000211323.1, RCV000211410.1, RCV000418019.1, RCV000435684.1, |